Concepedia

David F. Sciortino

DF

Statistics

Publications

11

Citations

256

H-Index

11

Active since

1995

Affiliations

University of Chicago(Current)

Cancer Research Center

Fort Wayne Medical Institute

University of Chicago Medical Center

Research Triangle Park Foundation

David F. Sciortino is an author at University of Chicago specializing in chemotherapy, medicine, and oncology.

Publications per year

1995–2010

11

Publications

11

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer

Everett E. Vokes, Rafat Ansari, Gregory A. Masters et al. · Annals of Oncology · 1998 · 35 citations · Full text

, , +14

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma

Sridhar Mani, David F. Sciortino, Brian L. Samuels et al. · Investigational New Drugs · 1999 · 33 citations

, , +5

Phase II Study of Doxorubicin and Paclitaxel as Second-Line Chemotherapy of Small-Cell Lung Cancer

Rafat Ansari, Paul Walker, David F. Sciortino et al. · American Journal of Clinical Oncology · 2000 · 33 citations

, , +16

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer

Sridhar Mani, John W. Kugler, James A. Knost et al. · Investigational New Drugs · 1998 · 33 citations

, , +8

A Comparison of Oral Ondansetron and Intravenous Granisetron for the Prevention of Nausea and Emesis Associated with Cisplatin‐Based Chemotherapy

Jesse I. Spector, Eric P. Lester, Eric Chevlen et al. · The Oncologist · 1998 · 23 citations · Full text

, , +17

1–5 of 11